For newly diagnosed ALK or EGFR + NSCLC with oligometastases to brain only and otherwise cN0-1 thoracic disease, would you offer targeted therapy alone or SRS to brain + concurrent chemoradiation/surgery to chest?
1 Answer
Mednet MemberInvited Expert
Medical Oncology · UCSD Moores Cancer Center
Answered on
For asymptomatic patients with smaller lesions, I would offer initial osimerinib or alectinib and get MRI with SRS planning sequences at 1month. We would then SRS any non-responding lesions
Join for free or sign in to see the full answer